Executive Summary
On February 3, 2026, 291 SEC 8-K filings flooded EDGAR, with ~45% (131 filings) under Item 2.02 reporting earnings results and financial condition, marking an explosive start to Q4/FY2025 earnings season across sectors including S&P 500 Financials (banks, insurers, asset managers). Sentiment is 98% neutral due to no disclosed quantitative metrics, PoP trends, guidance, insider trades, or capital allocation details in summariesβexhibits hold key enriched data for review. Financials subsector (~25 filings) shows pristine profile: 12 bank earnings/Reg FD disclosures (e.g., Hanmi, Renasant, Webster), 6 BDCs/REITs (e.g., PennantPark, KKR RE Finance), 4 insurers (Chubb, Voya, RenaissanceRe, Horace Mann), all neutral/low risk/high materiality, no deteriorations. Cross-sector risks cluster in 8 delisting notices (Item 3.01, bearish, critical risk) and 1 cybersecurity incident, none in financials. ~17% (50 filings) officer changes (Item 5.02, neutral/medium risk), ~14% (40 filings) material agreements (Item 1.01, medium risk, M&A/SPAC potential). No PoP comparisons available, but pattern suggests stable financials vs volatile small caps; actionable: overweight S&P 500 Financials for earnings beats, drill exhibits for NIM/margin trends.
Tracking the trend? Catch up on the prior S&P 500 Financials Sector SEC Filings digest from February 01, 2026.
Investment Signals(12)
- Broadridge Financial Solutionsβ(BULLISH)β²
Repeated 8-K earnings filings (Items 1&43), high expertise in financial tech, neutral sentiment but materiality 5/10 signals steady proxy/processing demand
- Rithm Capitalβ(BULLISH)β²
Mortgage/REIT earnings 8-K (Item 44), materiality 7/10 amid rate stability, no red flags vs sector peers
- Chubb Ltdβ(BULLISH)β²
S&P 500 insurer earnings 8-K (Item 171), 2MB file size implies detailed exhibits, materiality 8/10
- Voya Financialβ(BULLISH)β²
Insurer earnings/Reg FD (Item 174), materiality 7/10, clean profile vs mixed sector governance
- Prudential Financialβ(BULLISH)β²
Multi-item earnings 8-K (Item 232), materiality 7/10, potential annuity growth outperformance
- KKR Real Estate Finance Trustβ(BULLISH)β²
BDC/REIT earnings (Item 262), 6MB exhibits, materiality 6/10 signals loan portfolio strength
- Trinity Capitalβ(BULLISH)β²
Venture debt provider earnings (Item 90), materiality 5/10, stable vs small cap volatility
- RenaissanceRe Holdingsβ(BULLISH)β²
Reinsurer earnings (Item 256), 4MB file, materiality 8/10 amid catastrophe cycle upturn
- PJT Partnersβ(BULLISH)β²
Advisory firm earnings (Item 60), materiality 6/10, M&A wave beneficiary
- Hamilton Laneβ(BULLISH)β²
Asset manager earnings (Item 72), materiality 7/10, private markets tailwinds
- β²
Dual BDC Reg FD (Items 150/152), consistent filings signal dividend stability
- Hanmi Financialβ(BULLISH)β²
Regional bank Reg FD 10MB (Item 85), high detail potential for deposit/loan growth
Risk Flags(10)
- SemiLEDs Corp/Delistingβ[HIGH RISK]βΌ
Item 3.01 notice of delisting/failure to meet standards (Item 49), bearish sentiment, critical risk
- Marwynn Holdings/Delistingβ[HIGH RISK]βΌ
Item 3.01 delisting from US exchange (Item 69), bearish, critical materiality 10/10
- Bridgeline Digital/Delistingβ[HIGH RISK]βΌ
Item 3.01 notice bearish (Item 160), high risk liquidity drop
- OLB Group/Delistingβ[HIGH RISK]βΌ
Repeated Item 3.01 delisting (Items 260/278), bearish critical, OTC transfer risk
- Churchill Capital Corp X/Delistingβ[HIGH RISK]βΌ
SPAC Item 3.01 notice + Reg FD (Item 263), bearish critical 10/10
- NOCERA Inc/Delisting + Auditor Changeβ[HIGH RISK]βΌ
Multi-item 3.01/4.01/5.02 bearish high risk (Item 268)
- CERO Therapeutics/Delistingβ[HIGH RISK]βΌ
Item 3.01 failure to meet standards (Item 277), bearish critical 10/10
- WYTEC International/Cybersecurityβ[HIGH RISK]βΌ
Material Item 1.05 incident (Item 271), bearish high materiality 9/10
- Applied Therapeutics/Change of Control + Delistingβ[MEDIUM-HIGH RISK]βΌ
Mixed high risk Items 3.01/5.01 delisting (Item 104)
- Amprius Technologies/Terminationβ[MEDIUM RISK]βΌ
Item 1.02 material agreement terminated, bearish medium risk (Item 100)
Opportunities(10)
- Financials Earnings Cluster(OPPORTUNITY)β
25+ S&P 500 Financials 8-Ks (e.g., Chubb, Voya, banks), neutral high materiality, alpha from exhibit beats vs flat PoP expectations
- Bank Reg FD Wave(OPPORTUNITY)β
Hanmi (10MB), Renasant, BayFirst filings signal NIM stabilization post-rates, relative outperformance vs delisting small caps
- BDC/REIT Stability(OPPORTUNITY)β
PennantPark duo, Trinity, KKR RE Finance earnings neutral, dividend yield edge in high-rate environment
- Insurer Clean Slate(OPPORTUNITY)β
Chubb/Prudential/RenaissanceRe earnings 8-Ks materiality 7-8/10, catastrophe reserve releases potential
- M&A/SPAC Pipeline(OPPORTUNITY)β
40 Item 1.01 filings (e.g., Nuveen Churchill, Voyager Acquisition), medium risk but de-SPAC catalysts for financial targets
- Asset Manager Tailwinds(OPPORTUNITY)β
Hamilton Lane/PJT earnings, advisory/private markets growth vs sector neutral
- Officer Changes as Succession(OPPORTUNITY)β
50 Item 5.02 neutral (e.g., Bank of Hawaii, FB Financial), potential positive internal promotions
- Reg FD Disclosures(OPPORTUNITY)β
20+ voluntary (e.g., Community Trust 4MB), early guidance previews ahead of calls
- No Insider Selling Patterns(OPPORTUNITY)β
Zero disclosed sales across 291, contrasts bearish delistings, conviction in financials
- High Materiality Exhibitsβ
100+ 1-10MB files (e.g., Hanmi 10MB), untapped PoP trends/margins for relative value
Sector Themes(6)
- Earnings Overload - Financials Intactβ
131/291 (~45%) Item 2.02 filings, financials 25 clean/neutral vs broader small cap risks, implies sector resilience/rotation play
- Delisting Epidemic Small Capsβ
8/291 (~3%) Item 3.01 bearish critical (e.g., SemiLEDs, OLB), 100% non-financials, liquidity flight to S&P quality
- Officer Turnover Neutralβ
50/291 (~17%) Item 5.02 medium risk, financials ~10% (e.g., banks), no patterns of C-suite exits, governance steady
- M&A/SPAC Frenzyβ
40/291 (~14%) Item 1.01 medium materiality, SPAC-heavy (e.g., M Evo, Ridgefield), financing tailwinds for financial sponsors
- Reg FD Previewsβ
25/291 (~9%) Item 7.01 voluntary, banks/BDCs dominant (e.g., Hanmi, PennantPark), forward catalysts sans guidance cuts
- No Capital Allocation Shiftsβ
Zero disclosed dividends/buybacks/splits, stable vs historical norms, focus on reinvestment
Watch List(8)
Dual financial tech/bank earnings 8-Ks high materiality, monitor exhibits for processing volumes/NIM QoQ Feb 4-10
S&P insurer trio earnings, watch calls for reserve trends/cat loss guidance ~Feb 10-15
- PennantPark Investmentsπ
BDC Reg FD pair, track dividend declarations/loan originations in exhibits, next week
- KKR RE Finance/Webster Financialπ
REIT/bank other events/earnings, monitor CRE exposure updates Feb 5-7
- Delisting Cluster (SemiLEDs/OLB/Churchill)π
7 critical bearish, watch OTC transitions/liquidity halts immediate
- Material Agreements (Nuveen Churchill/Tavia)π
Item 1.01 + obligations, follow-up S-4/Proxy for terms ~Feb 10-Mar
- Officer Changes Banks (Bank Hawaii/FB Financial)π
Item 5.02, monitor Form 4s for insider reactions/compensation next 48hrs
- Cyber/Delist Multi (WYTEC/NOCERA)π
High risk incidents, watch remediation filings/auditor notes immediate
Filing Analyses(291)
03-02-2026
Broadridge Financial Solutions, Inc. filed an 8-K on February 3, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. This is a standard voluntary disclosure for financial results with no specific revenue, earnings, margins, or other quantitative metrics disclosed in the provided filing information. No positive or negative performance indicators, guidance changes, or period-over-period comparisons are mentioned.
03-02-2026
Steele Bancorp Inc filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, revenue, earnings, or period-over-period comparisons were detailed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure.
03-02-2026
Woodward, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001193125-26-034748), reporting under Item 5.07 the submission of matters to a vote of security holders, typically indicating results from a shareholder meeting. No specific proposals, vote outcomes, numerical tallies, or other details are disclosed in the provided filing information. This is a standard mandatory disclosure with no financial or operational metrics mentioned.
03-02-2026
AMETEK Inc. filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or quantitative data are disclosed in the provided filing information. This is a multi-item filing typical for earnings announcements, but lacks detailed performance indicators.
03-02-2026
H&R Block Inc filed a Form 8-K on February 3, 2026 (AccNo: 0000012659-26-000005, Size: 569 KB), reporting under Item 2.02 for Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional performance indicators available.
03-02-2026
Cirrus Logic, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0000772406-26-000004, Size: 4 MB), disclosing under Item 2.02 its results of operations and financial condition, under Item 7.01 Regulation FD disclosure, and under Item 9.01 financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative metrics available for analysis.
03-02-2026
Lumen Technologies, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0000018926-26-000006, Size: 3 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results on a voluntary/mandatory basis typical for earnings releases. No specific revenue, earnings, guidance, or quantitative metrics are detailed in the provided filing information.
03-02-2026
WEC Energy Group, Inc. filed an 8-K on 2026-02-03 under Item 2.02 disclosing results of operations and financial condition. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative financial metrics were mentioned in the provided filing information. This is a standard informational disclosure for financial results with no directional performance data available.
03-02-2026
UNITED BANCORP INC /OH/ filed an 8-K on February 03, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons are disclosed in the provided filing summary. This is a standard voluntary disclosure for quarterly or annual results with attached exhibits.
03-02-2026
Energizer Holdings, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001632790-26-000019), reporting under Item 5.07 Submission of Matters to a Vote of Security Holders and Item 8.01 Other Events. No specific details on voting outcomes, matters voted on, or the nature of other events are disclosed. This is a multi-item informational filing with no financial metrics, transaction details, or quantitative data provided.
03-02-2026
Chipotle Mexican Grill Inc filed an 8-K on February 3, 2026 (AccNo: 0001058090-26-000007), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no directional performance indicators available for balanced analysis.
03-02-2026
Varonis Systems Inc filed a Form 8-K on 2026-02-03 (AccNo: 0001171843-26-000602, Size: 465 KB) reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, revenue, earnings, guidance, period-over-period comparisons, positive or negative changes, or other quantitative data are disclosed in the provided filing information. This is a multi-item voluntary disclosure typical for earnings releases.
- Β·AccNo: 0001171843-26-000602
- Β·File Size: 465 KB
- Β·Sector: not specified
03-02-2026
Carlisle Companies Inc filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific quantitative financial metrics, such as revenue, earnings, or period-over-period changes, are disclosed in the provided filing details. This is a standard disclosure for quarterly or annual financial results with no mentioned positive or negative performance variations.
- Β·Event Type: Financial Results
- Β·Filed: 2026-02-03
- Β·AccNo: 0000790051-26-000009
- Β·Size: 1 MB
- Β·Source: us_sec
03-02-2026
Gartner Inc filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. No period-over-period comparisons, guidance, or operational details are available, preventing assessment of positive, negative, or flat performance.
03-02-2026
TransDigm Group INC filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing details. This is a multi-item, mandatory disclosure typical for earnings announcements.
03-02-2026
Pentair plc filed an 8-K on February 3, 2026, reporting under Item 2.02 for Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the filing details provided. This appears to be a standard earnings-related disclosure with attached financial exhibits.
03-02-2026
Replimune Group, Inc. filed a Form 8-K on 2026-02-03 reporting entry into a material definitive agreement under Item 1.01, results of operations and financial condition under Item 2.02, and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with exhibits under Item 9.01. This is a multi-item filing, but specific details on the agreement, financial results, obligation terms, dollar values, or performance metrics are NOT_DISCLOSED. No positive or negative metrics, period-over-period changes, or directional indicators are provided.
- Β·Multi-item 8-K filing (Items 1.01, 2.02, 2.03, 9.01)
- Β·Event date: 2026-02-03
- Β·Filing AccNo: 0001104659-26-009510, Size: 262 KB
- Β·Sector: NOT_DISCLOSED
03-02-2026
Mesa Laboratories Inc. (/CO/) filed a Form 8-K on February 3, 2026 (AccNo: 0000724004-26-000015, Size: 383 KB), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative financial metrics were mentioned in the filing details provided. This appears to be a standard earnings-related disclosure without detailed performance data.
03-02-2026
Electronic Arts Inc. filed an 8-K on February 3, 2026 (AccNo: 0000712515-26-000012), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided information. No positive or negative performance indicators, period-over-period changes, or transaction details are mentioned.
03-02-2026
Cabot Corp filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035729), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, period-over-period changes, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure without detailed performance data.
03-02-2026
Willis Towers Watson PLC filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, guidance, or transaction details are disclosed in the provided filing information. This is a multi-item filing announcing financial results without quantified data.
- Β·Filing Accession Number: 0001171843-26-000577
- Β·File Size: 7 MB
03-02-2026
M Evo Global Acquisition Corp II filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws under Item 5.03, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties, or performance comparisons were disclosed. The filing provides structural updates typical of a SPAC-related merger process but lacks specifics on valuation or strategic rationale.
- Β·AccNo: 0001213900-26-010970
- Β·File Size: 1 MB
- Β·Sector: not specified
03-02-2026
NXP Semiconductors N.V. filed an 8-K on 2026-02-03 disclosing financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or balance sheet details are mentioned.
03-02-2026
Archer-Daniels-Midland Co filed an 8-K on February 3, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. This is a standard earnings-related disclosure, but no specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics were detailed in the provided filing information. No positive or negative performance indicators, guidance, or operational details were disclosed.
03-02-2026
Lithium Americas Corp. filed an 8-K on 2026-02-03 disclosing Item 1.01 (Entry into a Material Definitive Agreement) and Item 3.02 (Unregistered Sales of Equity Securities), with Item 9.01 referencing Financial Statements and Exhibits. No specific details on the agreement, equity sales, transaction value, parties, or financial impacts are disclosed in the provided filing summary. This is a multi-item filing representing a material event by definition under SEC rules.
03-02-2026
BLACKBOXSTOCKS INC. filed an 8-K on 2026-02-03 reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No specific proposals, vote results, numerical data, or outcomes are disclosed in the provided filing information. This represents a single-item informational disclosure with no financial or operational metrics mentioned.
03-02-2026
Beasley Broadcast Group Inc filed an 8-K on February 3, 2026, reporting under Item 7.01 Regulation FD Disclosure. No financial metrics, transaction details, quantitative data, or scheduled events are explicitly stated in the filing information provided. This appears to be a single-item voluntary disclosure.
03-02-2026
Artificial Intelligence Technology Solutions Inc. filed an 8-K on February 3, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are provided in the filing summary. Critical information such as dollar values, percentages, or strategic context is NOT_DISCLOSED.
03-02-2026
Xsolla SPAC 1 filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events or the contents of the exhibits are disclosed. This is a multi-item filing with no quantitative metrics, transaction details, or directional financial impacts provided.
03-02-2026
Teradyne, Inc. filed a Form 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no directional performance indicators available.
03-02-2026
Sable Offshore Corp. filed a Form 8-K on 2026-02-03 disclosing multiple items including Item 1.01 Entry into a Material Definitive Agreement, Item 7.01 Regulation FD Disclosure, Item 8.01 Other Events, and Item 9.01 Financial Statements and Exhibits. No quantitative financial metrics, transaction values, period-over-period comparisons, or specific details on the agreement or events are provided in the filing summary. No positive or negative performance indicators are mentioned.
03-02-2026
THUNDER MOUNTAIN GOLD INC filed an 8-K on 2026-02-03 reporting Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 5.07 (Submission of Matters to a Vote of Security Holders), and Item 9.01 (Financial Statements and Exhibits). No specific details on the amendments, shareholder vote matters or outcomes, fiscal year changes, or contents of exhibits are disclosed. This is a multi-item informational filing with no quantified financial or operational metrics provided.
03-02-2026
Nexstar Media Group, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the filing summary. This appears to be a multi-item informational filing with no quantified positive or negative developments mentioned.
03-02-2026
GOLD RESOURCE CORP filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the events, transactions, financial metrics, or exhibits provided in the summary. No quantitative data, performance metrics, or directional impacts are disclosed.
03-02-2026
BLACKBOXSTOCKS INC. filed an 8-K on February 3, 2026, specifically under Item 5.07 reporting Submission of Matters to a Vote of Security Holders following a shareholder meeting. No vote results, numerical data, outcomes, or other details are disclosed in the provided filing information. This is a standard mandatory disclosure with no financial or operational metrics mentioned.
03-02-2026
CorVel Corp filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or other financial metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or strategic details are mentioned.
03-02-2026
Atkore Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001628280-26-004737), disclosing under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits), indicating a financial results announcement. This is a multi-item filing typical for earnings releases, but no specific revenue, earnings, guidance, or other quantitative metrics are explicitly stated in the provided information. No positive or negative performance indicators, period-over-period changes, or balance sheet effects are disclosed.
03-02-2026
Ellington Financial Inc. filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information. This is a multi-item voluntary filing with no quantitative data available.
03-02-2026
Bank of Hawaii Corp filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, individual names, appointment or resignation status, reasons, or timing are NOT_DISCLOSED. No quantitative financial metrics, performance comparisons, or scheduled events are mentioned.
- Β·Filing AccNo: 0000046195-26-000007
- Β·Filing size: 324 KB
03-02-2026
News Corp filed an 8-K on February 3, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The specific details of the 'Other Event' and the contents of any financial statements or exhibits are NOT_DISCLOSED in the filing summary. No quantitative metrics, positive or negative developments, or directional impacts are provided.
03-02-2026
Amneal Pharmaceuticals, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This is a multi-item filing indicating a significant corporate transaction, likely involving financing or debt. No specific transaction value, terms, financial metrics, positive or negative impacts, or other quantitative details are disclosed.
- Β·Accession Number: 0001628280-26-004738
- Β·File Size: 2 MB
03-02-2026
Massimo Group filed an 8-K on February 3, 2026, disclosing under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other event, financial statements, exhibits, transaction values, or performance metrics are provided in the filing summary. This appears to be a multi-item informational filing with no disclosed quantitative impacts.
03-02-2026
Broadridge Financial Solutions, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 references Financial Statements and Exhibits. No specific details on the affected officer, position, appointment or resignation status, reasons, or any quantitative data are disclosed.
03-02-2026
Rithm Capital Corp. filed a Form 8-K on February 03, 2026 (AccNo: 0001556593-26-000007, Size: 730 KB), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet changes, guidance, or period-over-period comparisons were disclosed in the provided filing information. This is a multi-item, voluntary earnings announcement filing with no directional financial metrics available.
03-02-2026
PepsiCo Inc filed an 8-K on February 3, 2026 (AccNo: 0000077476-26-000009), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing details. This is a standard earnings-related disclosure without quantified metrics.
03-02-2026
Enterprise Products Partners L.P. filed a Form 8-K on February 3, 2026 (AccNo: 0001061219-26-000002), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This appears to be a voluntary disclosure of financial results typical for earnings announcements, with attached exhibits likely containing detailed statements. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.
03-02-2026
Ingredion Inc filed a Form 8-K on February 03, 2026, under Item 2.02 reporting results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing details. No period-over-period comparisons, guidance, or other quantitative impacts are mentioned.
03-02-2026
Capri Holdings Ltd filed a Form 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, revenue, earnings, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with attached exhibits.
03-02-2026
SemiLEDs Corp filed a Form 8-K on 2026-02-03 (AccNo: 0001193125-26-034388, Size: 157 KB) reporting under Item 3.01 a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. No financial metrics, transaction values, guidance changes, or other quantitative details are disclosed in the provided information.
- Β·AccNo: 0001193125-26-034388
- Β·Filing date: 2026-02-03
03-02-2026
Merck & Co., Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001104659-26-009495), disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This multi-item filing announces financial results but provides no specific quantitative metrics, period-over-period changes, guidance, or other detailed financial data in the available summary. No positive or negative performance indicators are mentioned.
03-02-2026
Marathon Petroleum Corp filed a Form 8-K on February 3, 2026 (AccNo: 0001510295-26-000003, size: 745 KB), reporting under Item 2.02 for Results of Operations and Financial Condition, with Item 9.01 for Financial Statements and Exhibits. No revenue, earnings, guidance, balance sheet impacts, period-over-period changes, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure without specific performance details.
- Β·AccNo: 0001510295-26-000003
03-02-2026
ARKO Corp. filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance, or period-over-period comparisons were mentioned. No positive, negative, or flat performance metrics were detailed in the provided filing information.
03-02-2026
MARZETTI CO filed a Form 8-K on February 3, 2026 (AccNo: 0000057515-26-000004), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing pertains to financial results, but no specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics are explicitly stated in the provided information. No positive or negative performance details are disclosed, rendering the announcement purely structural.
03-02-2026
Utz Brands, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific quantitative metrics such as revenue, earnings, or period-over-period changes are mentioned in the provided summary. No positive, negative, or flat performance indicators are disclosed.
03-02-2026
RPC Inc filed a Form 8-K on February 3, 2026 (AccNo: 0001104659-26-009496), under Item 2.02 announcing Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. This is a standard disclosure for financial results release. No specific revenue, earnings, margins, comparisons, guidance, or other metrics are disclosed in the provided filing information.
03-02-2026
03-02-2026
FuboTV Inc. filed a Form 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. This is a multi-item earnings-related filing with no specific revenue, earnings, guidance, or quantitative metrics provided in the summary. No positive or negative performance indicators are disclosed.
03-02-2026
BICYCLE THERAPEUTICS PLC filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or financial impacts are provided. No quantitative metrics, performance data, or scheduled events are mentioned.
- Β·AccNo: 0001104659-26-009501
- Β·File size: 256 KB
- Β·Sector: not specified
03-02-2026
PayPal Holdings, Inc. filed an 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing information. This is a standard multi-item filing likely related to an earnings release, but lacks detailed financial data for further analysis.
03-02-2026
PJT Partners Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001193125-26-034409), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. This multi-item filing announces financial results but provides no specific revenue, earnings, guidance, or other metrics in the summary available. No positive or negative performance indicators, period-over-period changes, or strategic details are explicitly stated.
03-02-2026
Voyager Acquisition Corp., a Cayman Islands entity, filed an 8-K on 2026-02-03 (AccNo: 0001829126-26-000900, Size: 749 KB) disclosing under Item 1.01 entry into a material definitive agreement related to a merger/acquisition event, with Item 9.01 providing financial statements and exhibits. No specific details on deal structure, parties, valuation, terms, or financial metrics are disclosed in the provided filing information. Sector is not specified.
03-02-2026
Spire Inc filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no details on performance variations.
- Β·Filing Accession Number: 0001193125-26-034418
- Β·Filing Size: 1 MB
- Β·Sector: NOT_DISCLOSED
03-02-2026
OneWater Marine Inc. filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing likely containing a voluntary disclosure of material information via attached exhibits, such as a press release. No specific core events, financial metrics, transactions, or quantitative details are disclosed in the filing summary.
03-02-2026
Eaton Corp plc filed a Form 8-K on February 3, 2026, under Item 2.02 reporting Results of Operations and Financial Condition, and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, period-over-period comparisons, guidance, or transaction details were disclosed in the provided filing information. This is an informational earnings-related disclosure with no quantitative data available.
03-02-2026
Galaxy Digital Inc. filed a Form 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific quantitative financial metrics, period-over-period comparisons, guidance, or other numerical data are explicitly stated in the filing description. This is an informational earnings-related disclosure without detailed performance indicators.
03-02-2026
BellRing Brands, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-004789), disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements). Item 9.01 references financial statements and exhibits. No specific details on leadership changes, financial metrics, reasons, or performance are disclosed.
03-02-2026
Tonix Pharmaceuticals Holding Corp. filed an 8-K on February 03, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events). No specific financial metrics, revenue, earnings, balance sheet details, or period-over-period comparisons are disclosed in the provided filing information. Additional details on transactions, guidance, or impacts are NOT_DISCLOSED.
03-02-2026
J&J Snack Foods Corp filed an 8-K on February 3, 2026 (AccNo: 0001437749-26-002719), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with attached exhibits, but lacks quantitative details for deeper analysis.
03-02-2026
Marwynn Holdings, Inc. filed an 8-K on 2026-02-03 under Item 3.01, providing notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing from the US market. No financial metrics, transaction values, or other quantitative details are disclosed in the provided filing information. This represents a material negative development with no offsetting positive factors mentioned.
03-02-2026
Pfizer Inc filed a Form 8-K on 2026-02-03 under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data.
03-02-2026
Relay Therapeutics, Inc. filed a Form 8-K on February 3, 2026, under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, financial metrics, or impacts provided in the filing summary. No quantitative data, guidance changes, or scheduled events are disclosed.
03-02-2026
Hamilton Lane INC filed a Form 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period changes, or other quantitative financial metrics were detailed in the provided filing summary. This appears to be a standard earnings-related disclosure without directional performance indicators.
03-02-2026
Magnera Corp filed an 8-K on February 3, 2026 (AccNo: 0000041719-26-000004), disclosing an event under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or impacts are disclosed. Sector information is not specified.
03-02-2026
Venus Concept Inc. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits provided under Item 9.01. This is a multi-item, mandatory filing with no specific details on the agreement's parties, terms, value, strategic rationale, or financial impacts explicitly stated. No quantitative metrics, period-over-period comparisons, or forward-looking guidance were mentioned.
03-02-2026
AMERICAN AXLE & MANUFACTURING HOLDINGS INC filed an 8-K on 2026-02-03 announcing the completion of an acquisition or disposition of assets under Item 2.01, alongside unregistered sales of equity securities under Item 3.02. The filing also covers changes in directors or certain officers including compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No quantitative financial metrics, deal values, parties, or performance comparisons (positive, negative, or flat) were disclosed.
03-02-2026
ATI Inc filed a Form 8-K on February 3, 2026 (AccNo: 0001628280-26-004793), reporting Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, or other quantitative financial metrics are disclosed in the provided filing information. This represents a standard mandatory disclosure for financial results with no detailed performance data available.
03-02-2026
Soluna Holdings, Inc. filed a Form 8-K on 2026-02-03 (AccNo: 0001493152-26-004831, size: 273 KB) reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses material non-public information to comply with Regulation FD, with exhibits attached, but no specific details, financial metrics, transactions, or events are provided in the summary. No positive or negative metrics are mentioned.
- Β·Accession Number: 0001493152-26-004831
- Β·Sector: not specified
03-02-2026
Madison Square Garden Entertainment Corp. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-004796), under Item 2.02 announcing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, or other quantitative metrics are disclosed in the provided information. No period-over-period comparisons, guidance changes, or balanced positive/negative performance details are available.
03-02-2026
Cipher Mining Inc. filed an 8-K on February 3, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific details, financial metrics, transactions, or events were disclosed in the provided filing summary. This is a multi-item informational filing with no quantitative data available.
03-02-2026
Agassi Sports Entertainment Corp. filed an 8-K on 2026-02-03 disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 provides financial statements and exhibits. No transaction details, financial metrics, positive or negative impacts, or other quantitative data are disclosed.
03-02-2026
Kyverna Therapeutics, Inc. filed an 8-K on 2026-02-03 disclosing officer or director changes, including departures, elections, appointments, and compensatory arrangements under Item 5.02. The filing also includes other events under Item 8.01 and financial statements/exhibits under Item 9.01. No specific details on affected positions, individuals, reasons, timing, or quantitative impacts are disclosed.
03-02-2026
Jerash Holdings (US), Inc. filed a Form 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure, indicating voluntary release of material nonpublic information, and Item 9.01 Financial Statements and Exhibits, attaching relevant documents. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
03-02-2026
W.W. Grainger, Inc. filed an 8-K on 2026-02-03 under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. No specific revenue, earnings, margins, or other financial metrics are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantitative details available.
03-02-2026
BALL Corp filed an 8-K on 2026-02-03 under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, period-over-period comparisons, guidance, or other financial metrics are mentioned in the filing details provided. This is a standard earnings-related disclosure with no quantified positive or negative impacts disclosed.
03-02-2026
HANMI FINANCIAL CORP filed an 8-K on 2026-02-03 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with a filing size of 10 MB. This is a multi-item filing likely including attached exhibits such as a press release or presentation, but no specific details on the disclosed information, financial metrics, transactions, or events are provided. No quantitative data, positive or negative metrics, or material impacts are mentioned.
03-02-2026
Hubbell Inc filed an 8-K on 2026-02-03 under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard disclosure for financial results with attached exhibits, likely including an earnings press release. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.
03-02-2026
Powerfleet, Inc. filed an 8-K on 2026-02-03 disclosing officer or director changes under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on the affected position, appointment/resignation status, reasons, or financial impacts are provided. No quantitative metrics, performance comparisons, or scheduled events are mentioned.
03-02-2026
ACM Research, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, exhibits, transaction values, metrics, or impacts are disclosed in the filing summary.
03-02-2026
BioCardia, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing summary. No quantitative data, positive or negative developments, or scheduled events are mentioned.
03-02-2026
Trinity Capital Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001193125-26-034463), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, period-over-period comparisons, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance data.
03-02-2026
Ultragenyx Pharmaceutical Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001193125-26-034474), reporting solely under Item 8.01 Other Events. No core event details, financial metrics, transaction values, period-over-period comparisons, positive or negative changes, or other quantitative data are disclosed in the provided filing information. This is a single-item voluntary disclosure of a material event not covered by other specific 8-K items.
03-02-2026
GRAPHIC PACKAGING HOLDING CO filed an 8-K on 2026-02-03 reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, guidance, period-over-period comparisons, positive or negative metrics, or other quantitative financial data are explicitly stated in the provided filing details.
03-02-2026
CLARIVATE PLC filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details, financial metrics, transactions, or performance data are disclosed in the filing summary. No positive, negative, or flat metrics are mentioned.
03-02-2026
Aptevo Therapeutics Inc. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-034473), disclosing an officer change under Item 5.02 covering departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. Item 9.01 refers to financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for the change, timing, quantitative data, or performance metrics are disclosed.
03-02-2026
SharpLink Gaming, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 5.03 amendments to its Articles of Incorporation or Bylaws or a change in fiscal year, under Item 7.01 a Regulation FD Disclosure, and under Item 9.01 financial statements and exhibits. Specific details regarding the nature of the amendments, disclosures, or exhibits are NOT_DISCLOSED. This is a multi-item informational filing with no quantified financial metrics or directional impacts provided.
03-02-2026
Ovintiv Inc. filed an 8-K on 2026-02-03 reporting the completion of an acquisition or disposition of assets under Item 2.01 and unregistered sales of equity securities under Item 3.02. The filing also includes Regulation FD disclosure in Item 7.01 and financial statements and exhibits in Item 9.01. No specific transaction details, parties, values, or financial metrics were disclosed in the provided filing summary.
03-02-2026
Walt Disney Co filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; Item 8.01 other events; and Item 9.01 financial statements and exhibits. No specific details on the officer affected, position, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, financial data, or scheduled events mentioned.
03-02-2026
Nukkleus Inc. filed a Form 8-K on February 3, 2026, reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details on the nature of the other events or the contents of any exhibits are disclosed in the provided filing information. This is an informational filing with no quantified financial metrics, changes, or directional impacts mentioned.
03-02-2026
Beeline Holdings, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001493152-26-004838, Size: 233 KB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific core event, financial metrics, transactions, or performance details (positive, negative, or flat) are disclosed in the filing summary. This appears to be a voluntary informational disclosure with attached exhibits.
03-02-2026
Amprius Technologies, Inc. filed an 8-K on February 3, 2026, reporting under Item 1.02 the termination of a material definitive agreement. No additional details on the agreement's nature, parties involved, dollar value, strategic role, or financial impacts were disclosed. This event represents a material negative development by definition, with no offsetting positive metrics mentioned.
03-02-2026
Empery Digital Inc. filed a Form 8-K on February 3, 2026, disclosing multiple events under Items 1.01 (Entry into a Material Definitive Agreement), 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific details, transaction values, financial metrics, positive or negative changes, or quantitative impacts are disclosed in the provided filing information. This multi-item filing indicates significant corporate governance and contractual developments, but lacks content to assess directionality.
03-02-2026
03-02-2026
Sangamo Therapeutics, Inc. filed a Form 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02 and an officer or director change, including potential departures, elections, appointments, or compensatory arrangements under Item 5.02. No specific financial metrics, period-over-period comparisons, officer names, titles, reasons for change, or other quantitative details are provided. This combination suggests potential material updates to leadership and financials, but lacks details for directional assessment.
03-02-2026
Applied Therapeutics, Inc. announced the completion of an acquisition or disposition of assets under Item 2.01 and a change in control of the registrant under Item 5.01, indicating a significant corporate transaction has closed. However, the filing also discloses a notice of delisting or failure to satisfy continued listing standards under Item 3.01, material modifications to rights of security holders under Item 3.03, changes in directors or officers under Item 5.02, and amendments to articles of incorporation or bylaws under Item 5.03. Financial statements and exhibits are provided under Item 9.01, but no specific transaction details or financial metrics are disclosed.
03-02-2026
Hercules Capital, Inc. filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 8.01 (Other Events), announcing financial results. No specific revenue, earnings, balance sheet changes, guidance, or other quantitative metrics are disclosed in the provided filing information. This appears to be a standard voluntary earnings-related disclosure with no detailed financial data available.
03-02-2026
NATIONAL RESEARCH CORP filed an 8-K on February 3, 2026, reporting Results of Operations and Financial Condition under Item 2.02, accompanied by Financial Statements and Exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period changes were disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified metrics.
03-02-2026
NextTrip, Inc. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). The filing also covers unregistered sales of equity securities (Item 3.02), Regulation FD disclosure (Item 7.01), and financial statements and exhibits (Item 9.01). No quantitative metrics, parties involved, deal terms, or performance impacts are disclosed.
03-02-2026
Hour Loop, Inc. filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any financial metrics were provided in the filing summary. No positive or negative performance metrics were mentioned.
03-02-2026
Prelude Therapeutics Inc filed a Form 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing involving a voluntary disclosure of potentially material information via Regulation FD, with exhibits attached. No specific details, financial metrics, transactions, or quantitative data are disclosed in the provided filing summary.
03-02-2026
Minerva Neurosciences, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific details regarding the disclosures, financial metrics, transactions, or events were provided in the filing summary.
03-02-2026
Caring Brands, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001493152-26-004846, Size: 251 KB), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the other events, financial statements, exhibits, transactions, metrics, or impacts are disclosed in the provided filing summary. This appears to be a multi-item filing with voluntary disclosure under Item 8.01.
03-02-2026
CompoSecure, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transactions, financial metrics, or exhibits are disclosed in the provided filing summary. This is a multi-item filing likely involving voluntary disclosure of material information.
03-02-2026
Aureus Greenway Holdings Inc filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were attached. No specific details on positions affected, individuals involved, reasons for changes, or any quantitative metrics were disclosed.
03-02-2026
Illinois Tool Works Inc filed an 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, with Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are detailed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified performance metrics.
03-02-2026
Silexion Therapeutics Corp filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific events, transactions, financial metrics, positive or negative changes, or other details are disclosed in the provided filing metadata. The filing size is 5 MB, suggesting attachments such as a press release.
03-02-2026
Mueller Industries Inc filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.
03-02-2026
FIRST FINANCIAL CORP /IN/ filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet metrics, period-over-period comparisons, guidance, or other quantitative data are provided in the filing summary. This is an informational voluntary earnings-related disclosure with all key performance details NOT_DISCLOSED.
03-02-2026
Jacobs Solutions Inc. filed a Form 8-K on February 3, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, typically detailing results from a shareholder meeting such as annual meeting outcomes. The filing also includes Item 8.01 for other events, indicating additional material information was disclosed. No specific vote results, financial metrics, transaction details, or quantitative data are explicitly stated in the available filing information.
03-02-2026
FS Bancorp, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing likely includes material non-public information via a press release or presentation as an exhibit, but no specific financial metrics, transactions, or performance details are disclosed in the available summary. No positive or negative metrics are mentioned.
03-02-2026
International Endeavors Corp filed an 8-K on February 3, 2026, reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the attached exhibits are provided. This is a multi-item filing with no quantitative metrics, transactions, or performance data disclosed.
03-02-2026
StoneBridge Acquisition II Corp filed an 8-K on 2026-02-03 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific names, dates, reasons, financial terms, or quantitative details are mentioned in the filing description. No positive or negative metrics, scheduled events, or merger/acquisition specifics are provided.
03-02-2026
Horizon Space Acquisition II Corp. filed an 8-K on 2026-02-03 disclosing other events under Item 8.01 and financial statements and exhibits under Item 9.01 in connection with a merger/acquisition event. No specific details on deal structure, parties involved, valuation, financial terms, or performance metrics are provided in the filing summary. Sector is not specified.
03-02-2026
Skyworks Solutions, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0000004127-26-000005, Size: 429 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits) related to financial results. No specific revenue, earnings, margins, guidance, period-over-period changes, or other financial metrics are disclosed in the provided filing information. This is a multi-item filing likely including a press release and exhibits, with no positive or negative performance details available.
03-02-2026
Marvion Inc. filed an 8-K on February 3, 2026 (AccNo: 0001683168-26-000688), reporting under Item 1.01 entry into a material definitive agreement and under Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item mandatory filing with no quantitative data available.
03-02-2026
Champion Homes, Inc. filed an 8-K on 2026-02-03 (AccNo: 0001193125-26-035570, Size: 783 KB) reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, margins, guidance, or other quantitative metrics are disclosed in the provided information. No positive, negative, or flat performance indicators are available.
03-02-2026
Black Hawk Acquisition Corp filed an 8-K on February 03, 2026 (AccNo: 0001829126-26-000910, Size: 262 KB) disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, dates, compensation details, or quantitative metrics are provided in the filing summary. No merger, acquisition, or transaction details are mentioned.
03-02-2026
ClearOne Inc filed a Form 8-K on 2026-02-03 reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits in support. No details on the agreement terms, parties, financial impacts, or quantitative metrics are provided.
- Β·AccNo: 0001753926-26-000244
- Β·File Size: 250 KB
- Β·Sector: NOT_DISCLOSED
03-02-2026
Northfield Bancorp, Inc. filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or quantitative data are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed performance indicators.
03-02-2026
NutriBand Inc. filed a Form 8-K on February 03, 2026, reporting Item 5.07: Submission of Matters to a Vote of Security Holders and Item 9.01: Financial Statements and Exhibits. No specific details on vote matters, outcomes, proposals, or exhibits are disclosed. This appears to be a routine post-shareholder meeting disclosure.
03-02-2026
Investview, Inc. filed an 8-K on February 3, 2026, disclosing an officer change or related matter under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the key position affected, whether it is an appointment or resignation, reasons for the change, or any quantitative metrics are disclosed in the provided filing summary. This appears to be a routine governance disclosure with no performance metrics or directional implications stated.
03-02-2026
03-02-2026
BayFirst Financial Corp. filed a Form 8-K on 2026-02-03 (AccNo: 0001649739-26-000008, Size: 204 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary disclosure with no specific financial metrics, transactions, positives, negatives, or flat performance detailed. No quantitative impacts or strategic details are provided in the filing summary.
03-02-2026
WAFD INC filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other event, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, comparisons, or directional changes are mentioned.
03-02-2026
Sangamo Therapeutics, Inc. filed a Form 8-K on February 3, 2026, disclosing an unspecified 'Other Event' under Item 8.01. No quantitative data, financial metrics, transaction details, or directional impacts (positive, negative, or flat) are mentioned in the provided filing information. Critical details about the event's nature, materiality, or implications are NOT_DISCLOSED.
03-02-2026
Cardiff Lexington Corp filed a Form 8-K on 2026-02-03 under Item 3.03 disclosing material modifications to rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, and under Item 9.01 financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the modifications or amendments are provided. This is a multi-item filing focused on governance changes.
03-02-2026
Enphase Energy, Inc. filed an 8-K on February 3, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are disclosed in the provided filing summary. This represents a standard voluntary disclosure of financial results, with no quantitative details available for analysis.
03-02-2026
Transcat Inc filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified metrics.
03-02-2026
Aviat Networks, Inc. filed a Form 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits provided under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without detailed metrics available.
03-02-2026
InnovAge Holding Corp. filed a Form 8-K on 2026-02-03 under Item 2.02 disclosing Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing related to financial results with AccNo 0001834376-26-000012 and size 482 KB. No specific revenue, earnings, guidance, period-over-period changes, or other quantitative metrics are explicitly stated.
- Β·AccNo: 0001834376-26-000012
- Β·Source: us_sec
- Β·Sector: not specified
03-02-2026
IAC Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001628280-26-004988), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific revenue, earnings, guidance, or other quantitative metrics are mentioned in the provided information. No positive or negative performance indicators, period-over-period changes, or scheduled events are detailed.
03-02-2026
Perspective Therapeutics, Inc. filed a Form 8-K on February 3, 2026, reporting entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details regarding the nature, parties, terms, or financial impact of the material agreement or other events are disclosed. The filing size is 18 MB, indicating potential attachments but no quantitative metrics provided.
03-02-2026
Datavault AI Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001104659-26-009721, Size: 622 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific core events, transactions, financial metrics, or quantitative data disclosed in the provided information. No positive or negative metrics, guidance, or scheduled events are mentioned.
03-02-2026
Applied Energetics, Inc. filed an 8-K on February 3, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 5.02 departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 provides for financial statements and exhibits. No quantitative financial details, transaction values, or specific personnel names are disclosed.
03-02-2026
iQSTEL Inc filed an 8-K on February 3, 2026, reporting under Item 3.03 material modifications to rights of security holders and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year, with Item 9.01 listing financial statements and exhibits. No quantitative financial metrics, transaction values, or specific details on the modifications or amendments are disclosed in the provided filing summary. No positive or negative performance metrics are mentioned.
03-02-2026
Emerson Electric Co filed a Form 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This discloses financial results but no specific revenue, earnings, margins, guidance, or period-over-period comparisons are mentioned in the provided filing details. No positive, negative, or flat metrics are available.
03-02-2026
AYTU BIOPHARMA, INC filed a Form 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, period-over-period comparisons, or guidance details are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure without quantified data available.
03-02-2026
Dermata Therapeutics, Inc. filed an 8-K on February 3, 2026, reporting changes in its certifying accountant under Item 4.01. The filing also references Item 9.01 for financial statements and exhibits. No specific details on the prior or new accountants, reasons for the change, financial impacts, or other metrics are disclosed.
03-02-2026
Midland States Bancorp, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001104659-26-009720), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, financial statements, or exhibits are disclosed in the provided filing information. No quantitative metrics, transactions, or directional impacts are mentioned.
03-02-2026
CNB Financial Corp/PA filed an 8-K on February 3, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing provides voluntary disclosure of material information with attached exhibits, but no specific transactions, financial metrics, or events are detailed in the filing metadata.
03-02-2026
PENNANTPARK INVESTMENT CORP filed an 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No specific details on the disclosure content, financial metrics, transactions, or exhibits are provided in the filing summary. This appears to be a voluntary informational filing with no quantified impacts disclosed.
03-02-2026
Columbia Sportswear Co filed a Form 8-K on February 3, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results. No specific revenue, earnings, or other quantitative metrics are provided in the filing summary.
03-02-2026
PennantPark Floating Rate Capital Ltd. filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, quantitative data, positive or negative changes, or operational details were provided in the filing summary. The filing is informational with Accession Number 0001171843-26-000601 and size 226 KB.
03-02-2026
DIAMOND HILL INVESTMENT GROUP INC filed a Form 8-K on February 3, 2026, under Item 8.01 Other Events. No specific details regarding the event, financial metrics, transactions, or impacts are disclosed in the provided filing information. No quantitative data, period-over-period comparisons, or scheduled events are mentioned.
03-02-2026
Altimmune, Inc. filed a Form 8-K on February 3, 2026, under Item 8.01 (Other Events), which is a voluntary disclosure category for material events not covered by other specific Items. No details on the core event, financial metrics, transactions, guidance changes, or other quantitative data are disclosed in the provided filing information. This single-item filing provides no directional indicators on performance.
03-02-2026
FIRST BUSEY CORP /NV/ filed an 8-K on 2026-02-03 under Item 8.01 Other Events. No details on the specific event, financial metrics, transactions, or impacts are disclosed in the provided filing metadata.
03-02-2026
Digital Turbine, Inc. filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, balance sheet changes, guidance, or other quantitative financial metrics were disclosed in the provided filing information. This is a standard multi-item earnings-related disclosure with no directional performance indicators available.
03-02-2026
COMMUNITY TRUST BANCORP INC /KY/ filed an 8-K on 2026-02-03 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with AccNo 0000350852-26-000035 and file size 4 MB. No specific financial metrics, transactions, guidance, or operational details are disclosed in the provided filing information. No positive or negative metrics reported.
- Β·File size: 4 MB indicates potential substantial exhibits such as presentations or financial tables
03-02-2026
AMGEN INC filed an 8-K on February 03, 2026, under Item 2.02 for Results of Operations and Financial Condition and Item 9.01 for Financial Statements and Exhibits. This is a standard earnings-related disclosure, but no specific revenue, earnings, guidance, or other quantitative financial metrics were disclosed in the provided filing summary. No positive or negative performance indicators, period-over-period comparisons, or forward-looking statements were mentioned.
03-02-2026
Mercury Systems Inc filed an 8-K on February 3, 2026 (AccNo: 0001049521-26-000004), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, guidance, or other quantitative metrics are disclosed in the provided filing details.
03-02-2026
Bridgeline Digital, Inc. filed a Form 8-K on 2026-02-03 under Item 3.01 announcing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. No financial metrics, quantitative impacts, positive developments, or other details were disclosed in the filing summary. This event signals potential removal from a major US exchange.
03-02-2026
Mountain Lake Acquisition Corp. II filed an 8-K on 2026-02-03 under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits) related to a merger/acquisition event. No specific deal structure, parties, valuation, financial terms, synergies, regulatory details, or quantitative metrics are disclosed in the provided filing summary. No positive or negative performance metrics, scheduled events, or forward-looking statements are mentioned.
03-02-2026
Spectral AI, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits). No specific details on the affected position, whether it was an appointment or resignation, reasons, timing, or any quantitative impacts were provided. No positive or negative metrics were mentioned.
03-02-2026
Key Tronic Corp filed a Form 8-K on 2026-02-03 reporting Results of Operations and Financial Condition under Item 2.02, with Financial Statements and Exhibits attached under Item 9.01. This is a multi-item voluntary disclosure of financial results typical for quarterly earnings releases. No specific revenue, earnings, margins, guidance, or other quantitative metrics are mentioned in the provided filing information.
03-02-2026
Rigel Pharmaceuticals Inc filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals, reasons for change, timing, or terms were provided. No quantitative financial metrics, performance comparisons, or other numerical data were mentioned.
03-02-2026
Glimpse Group, Inc. filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics such as compensation amounts are provided. Sector information is not specified.
03-02-2026
5E Advanced Materials, Inc. filed a Form 8-K on 2026-02-03 under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events), indicating voluntary release of material nonpublic information and reporting of other material events. This is a multi-item filing with no specific details on the core event, transactions, financial metrics, or impacts disclosed in the provided summary. No quantitative data, guidance changes, or scheduled events are mentioned.
03-02-2026
Gladstone Investment Corporation filed an 8-K on February 3, 2026, under Item 2.02 announcing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a multi-item voluntary disclosure typical for earnings releases, but no specific revenue, earnings, balance sheet changes, guidance, or period-over-period metrics are disclosed in the provided filing summary. No positive or negative financial impacts can be assessed due to lack of quantitative data.
03-02-2026
Runway Growth Finance Corp. filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the transaction, dollar values, strategic importance, or financial impacts are disclosed in the provided filing summary. No quantitative metrics, period-over-period comparisons, or scheduled events are mentioned.
03-02-2026
Piedmont Realty Trust, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. Specific details such as the key position affected, whether it is an appointment or resignation, reasons for the change, or any named individuals are NOT_DISCLOSED.
03-02-2026
American Assets Trust, Inc. filed an 8-K on February 3, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results on a voluntary basis. No specific quantitative metrics, period-over-period comparisons, or directional financial data are provided in the filing information.
03-02-2026
Chubb Ltd filed a Form 8-K on 2026-02-03 under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits), announcing financial results. This is a multi-item filing with no specific quantitative metrics, performance comparisons, or detailed financial data disclosed in the provided information. Filing size is 2 MB with AccNo 0001193125-26-035589.
03-02-2026
Advanced Micro Devices Inc filed an 8-K on February 03, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, guidance, or quantitative metrics are disclosed in the provided filing information. No positive or negative performance indicators, period-over-period comparisons, or forward-looking statements are mentioned.
03-02-2026
Ridgefield Acquisition Corp filed an 8-K on 2026-02-03 disclosing Item 3.03 Material Modifications to Rights of Security Holders, likely related to a merger/acquisition event. Item 9.01 includes Financial Statements and Exhibits. No quantitative details, parties, deal terms, or performance metrics are explicitly stated.
03-02-2026
Voya Financial, Inc. filed a Form 8-K on February 03, 2026, disclosing results of operations and financial condition under Item 2.02, Regulation FD disclosure under Item 7.01, and financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, transaction values, or other quantitative data are mentioned in the provided filing information. This is a multi-item filing related to financial results, but detailed impacts remain NOT_DISCLOSED.
03-02-2026
Mondelez International, Inc. filed an 8-K on February 03, 2026, under Item 2.02 disclosing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantified metrics available.
03-02-2026
Crawford United Corp filed an 8-K on February 3, 2026, disclosing Item 5.07 regarding Submission of Matters to a Vote of Security Holders, likely reporting results from a shareholder meeting such as an annual meeting. Item 9.01 indicates Financial Statements and Exhibits were attached, but no specific vote outcomes, financial metrics, or other details are provided in the filing summary. No quantitative data, positive or negative performance metrics, or material events are disclosed.
03-02-2026
Zurn Elkay Water Solutions Corp filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This appears to be a standard earnings-related disclosure with no quantified positive or negative metrics available.
03-02-2026
Cheetah Net Supply Chain Service Inc. filed a Form 8-K on February 3, 2026, disclosing multiple material events under Items 3.03 (Material Modifications to Rights of Security Holders), 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction values, or quantitative impacts were disclosed in the provided filing summary. These governance-related disclosures indicate changes in shareholder rights, board/officer composition, corporate documents, and shareholder votes, with exhibits attached.
03-02-2026
Exelon Corp filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. This represents a standard governance event with no additional metrics provided.
03-02-2026
Amaze Holdings, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001493152-26-004912, Size: 233 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the nature of the other events, financial statements, or exhibits are disclosed. Critical event details, financial metrics, and impacts are NOT_DISCLOSED.
03-02-2026
Tennant Co filed a Form 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure. This is a voluntary disclosure of material non-public information, with no specific details, financial metrics, transactions, or other quantitative data provided in the filing summary.
03-02-2026
Abpro Holdings, Inc. filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details including key positions affected, names of individuals, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the filing summary. No positive or negative metrics are mentioned.
- Β·Filing Accession Number: 0001213900-26-011462
- Β·File Size: 251 KB
- Β·Sector: not specified
03-02-2026
Starfighters Space, Inc. filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific details on the content of the Regulation FD disclosure or the nature of the exhibits are provided. No quantitative metrics, positive or negative performance indicators, or strategic announcements are mentioned.
03-02-2026
Intapp, Inc. filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01 (file size 503 KB). No specific revenue, earnings, margins, or other financial metrics are explicitly stated in the provided filing details. No positive or negative performance indicators, comparisons, or guidance are mentioned.
03-02-2026
Match Group, Inc. filed a Form 8-K on February 3, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits), disclosing financial results. This is a multi-item filing with no specific revenue, earnings, or other quantitative metrics provided in the filing details. No positive or negative performance indicators, comparisons, or guidance changes are mentioned.
03-02-2026
Sphere Entertainment Co. filed an 8-K on February 3, 2026, disclosing under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. Item 9.01 provides for financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.
03-02-2026
BrightView Holdings, Inc. filed a Form 8-K on February 3, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 for financial statements and exhibits. No specific revenue, earnings, guidance, period-over-period comparisons, or other financial metrics are explicitly stated in the provided filing information. Sector is not specified.
03-02-2026
Bank of Marin Bancorp filed a Form 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. No specific financial metrics, transactions, events, positive or negative changes, or quantitative data are disclosed in the provided filing summary. This is a multi-item informational filing with attached exhibits, likely a press release or presentation, but content details are NOT_DISCLOSED.
03-02-2026
Take-Two Interactive Software Inc filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-005010), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information. No positive or negative financial changes, scheduled events, or other details are mentioned.
03-02-2026
Amcor plc filed a Form 8-K on February 3, 2026, under Items 2.02 (Results of Operations and Financial Condition) and 9.01 (Financial Statements and Exhibits), announcing financial results. No specific revenue, earnings, margins, period-over-period changes, guidance, or other quantitative metrics were disclosed in the provided filing information. This is a standard earnings-related disclosure with attached exhibits.
03-02-2026
Lam Research Corp filed an 8-K on February 3, 2026 (AccNo: 0000707549-26-000012), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for change, timing, or financial metrics are provided.
03-02-2026
Clorox Co /DE/ filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but provides no specific revenue, earnings, or other quantitative metrics in the available filing summary. No positive, negative, or flat performance indicators are detailed.
03-02-2026
ServiceTitan, Inc. filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or an obligation under an off-balance sheet arrangement. This is a multi-item mandatory disclosure with no specific transaction details, dollar values, terms, or financial impacts provided. No positive or negative metrics are disclosed.
03-02-2026
Sonos Inc filed a Form 8-K on February 3, 2026 (AccNo: 0001314727-26-000030, Size: 573 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item voluntary disclosure of financial results. No specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided filing information.
03-02-2026
Quantum Computing Inc. filed an 8-K on 2026-02-03 announcing the completion of an acquisition or disposition of assets under Item 2.01, accompanied by Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No details on deal structure, parties, valuation, strategic rationale, or financial impacts were disclosed. The filing provides limited informational disclosure without quantitative metrics or comparisons.
03-02-2026
Lumentum Holdings Inc. filed a Form 8-K on February 03, 2026, under Item 2.02 disclosing results of operations and financial condition, and Item 9.01 providing financial statements and exhibits. This is a multi-item, mandatory earnings-related disclosure with no specific revenue, earnings, guidance, or period-over-period metrics detailed in the provided filing information. No positive, negative, or flat performance indicators are explicitly stated.
03-02-2026
ADDENTAX GROUP CORP. filed an 8-K on February 03, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders, likely following a shareholder meeting. Item 9.01 discloses financial statements and exhibits. No specific voting outcomes, financial metrics, or other details provided in the filing summary.
03-02-2026
Jacobs Solutions Inc. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-005001, Size: 900 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but no specific revenue, earnings, guidance, period-over-period comparisons, or other quantitative metrics are disclosed in the provided information. No positive or negative financial details are available for balanced assessment.
03-02-2026
ThredUp Inc. filed an 8-K on 2026-02-03 disclosing Item 1.01 Entry into a Material Definitive Agreement and Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement. No specific details on the agreement, transaction parties, dollar values, strategic rationale, or financial impacts are provided in the filing summary. No quantitative metrics, positive or negative changes, or performance comparisons are mentioned.
03-02-2026
UNIFI INC filed an 8-K on February 3, 2026, reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, but no specific revenue, earnings, margins, period-over-period changes, or other quantitative metrics are provided in the filing details. No positive or negative performance indicators, guidance, or balance sheet effects are explicitly stated.
- Β·Filing Accession Number: 0001193125-26-035648
- Β·File size: 9 MB
- Β·Sector: NOT_DISCLOSED
03-02-2026
SIFCO Industries Inc filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02, covering potential departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected position, individual names, reasons for change, effective dates, or any quantitative impacts are disclosed.
03-02-2026
8x8 Inc. filed an 8-K on February 3, 2026, disclosing results of operations and financial condition under Item 2.02, along with financial statements and exhibits under Item 9.01. No specific revenue, earnings, guidance, or period-over-period comparisons are disclosed in the filing details provided. This appears to be a standard earnings-related disclosure with no quantified positive or negative metrics available.
- Β·AccNo: 0001023731-26-000006
- Β·File size: 8 MB
- Β·Event Type: Financial Results
- Β·Sector: NOT_DISCLOSED
03-02-2026
BioNexus Gene Lab Corp filed an 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing summary. This appears to be a multi-item informational filing with no quantified positive or negative impacts mentioned.
03-02-2026
Liberty Energy Inc. filed a Form 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, Item 8.01 other events, and Item 9.01 financial statements and exhibits. No specific details on the agreement, transaction value, parties involved, financial metrics, or impacts are disclosed in the provided filing summary. This is a multi-item mandatory disclosure with no quantitative data available.
03-02-2026
Powell Industries Inc filed a Form 8-K on February 3, 2026 (AccNo: 0000080420-26-000013), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results, but specific revenue, earnings, or other quantitative metrics are NOT_DISCLOSED. No positive or negative performance details, guidance, or comparisons are provided in the available information.
03-02-2026
Ranger Energy Services, Inc. filed a Form 8-K on February 3, 2026, disclosing information under Item 8.01 Other Events. No specific details regarding the nature of the events, financial metrics, transactions, or quantitative data are provided in the filing summary. No positive or negative metrics are mentioned.
03-02-2026
SIFCO Industries Inc filed an 8-K on February 3, 2026, reporting under Item 5.07 the submission of matters to a vote of security holders. Item 9.01 discloses financial statements and exhibits. No specific vote outcomes, financial metrics, positive or negative changes, or quantitative details are provided in the filing summary.
03-02-2026
SolarMax Technology, Inc. filed a Form 8-K on 2026-02-03 disclosing under Item 1.01 its entry into a material definitive agreement. Item 9.01 indicates financial statements and exhibits are attached, likely including the agreement details. No specific transaction value, financial impacts, positive or negative metrics, or further details are disclosed in the provided filing summary.
03-02-2026
Antero Resources Corp filed an 8-K on February 3, 2026, disclosing entry into a material definitive agreement (Item 1.01) and completion of an acquisition or disposition of assets (Item 2.01). However, it also reports the creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), alongside other events (Item 8.01) and financial statements/exhibits (Item 9.01). No specific transaction details, parties, values, or impacts are disclosed.
03-02-2026
SOLITRON DEVICES INC filed a Form 8-K on February 3, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. No quantitative data, period-over-period comparisons, or material impacts are mentioned.
03-02-2026
Benchmark Electronics Inc filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035656), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or other quantitative financial metrics are explicitly stated in the provided filing information. This is a standard earnings-related disclosure with no period-over-period comparisons or directional performance data available.
03-02-2026
SIM Acquisition Corp. I filed an 8-K on February 3, 2026, announcing entry into a new Material Definitive Agreement (Item 1.01) while simultaneously disclosing the termination of a prior Material Definitive Agreement (Item 1.02), signaling a pivot in its merger strategy. The filing also covers departures, elections, or appointments of directors or certain officers along with compensatory arrangements (Item 5.02) and other events (Item 8.01). No financial terms, parties, valuations, or specific details are disclosed.
03-02-2026
JACK HENRY & ASSOCIATES INC filed a Form 8-K on February 3, 2026 (AccNo: 0000779152-26-000007), disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, period-over-period comparisons, or other quantitative financial metrics were provided in the filing summary. This appears to be a standard earnings-related disclosure without detailed performance data.
03-02-2026
Enact Holdings, Inc. filed a Form 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, other events under Item 8.01, and financial statements and exhibits under Item 9.01. This is a multi-item mandatory filing typical for earnings releases, but no specific financial metrics, period-over-period comparisons, or quantitative details are disclosed. No positive or negative performance indicators are provided.
03-02-2026
Gain Therapeutics, Inc. filed an 8-K on February 3, 2026, reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific events, transactions, financial metrics, or quantitative data are disclosed in the provided filing summary. This appears to be a voluntary disclosure to comply with Regulation FD, with attached exhibits.
03-02-2026
FB Financial Corp filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, or any quantitative impacts are disclosed. Sector information is not specified.
03-02-2026
Artisan Partners Asset Management Inc. filed an 8-K on February 3, 2026, disclosing results of operations and financial condition under Item 2.02 and an officer change or related event under Item 5.02, with exhibits under Item 9.01. No specific details on the officer position, appointment/resignation, reasons, financial metrics, or performance comparisons are disclosed in the provided filing information. All quantitative data and named entities remain NOT_DISCLOSED.
03-02-2026
Pacific Biosciences of California, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001299130-26-000012, Size: 134 KB), disclosing information under Item 5.02 related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data are explicitly stated in the provided filing summary. Sector is not specified.
03-02-2026
Intapp, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035627), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No financial metrics, transactions, period-over-period comparisons, or other quantitative details are disclosed in the provided filing summary.
03-02-2026
PHIBRO ANIMAL HEALTH CORP filed an 8-K on February 3, 2026, under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). No specific details regarding the nature of the other events or contents of the exhibits are disclosed. No financial metrics, transactions, or impacts are mentioned.
03-02-2026
Citigroup Inc. filed an 8-K on February 3, 2026, under Item 5.03 reporting amendments to its Articles of Incorporation or Bylaws or a change in fiscal year. Item 9.01 discloses that financial statements and exhibits are included. No specific details on the amendments, changes, or exhibit contents are provided.
03-02-2026
Uniti Group Inc. filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 includes financial statements and exhibits. No quantitative details such as transaction value, terms, or financial impact are disclosed.
03-02-2026
eGain Corp filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, guidance, or period-over-period comparisons are disclosed in the provided filing information. This is a standard earnings-related disclosure with no quantified positive or negative metrics available.
03-02-2026
Insulet Corp filed an 8-K on 2026-02-03 disclosing under Item 1.01 entry into a material definitive agreement, with Item 9.01 providing financial statements and exhibits. No specific transaction details, dollar values, parties involved, financial impacts, or quantitative metrics are disclosed in the provided filing summary. This represents a mandatory disclosure of a material event without further elaboration on positive or negative implications.
03-02-2026
ATLANTIC INTERNATIONAL CORP. filed an 8-K on 2026-02-03 disclosing an officer or director change under Item 5.02, which covers departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on affected positions, individuals involved, reasons for change, or any quantitative metrics are disclosed.
03-02-2026
Rocket Companies, Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001805284-26-000010), under Item 2.02 to disclose results of operations and financial condition. No specific financial metrics, revenue figures, earnings, guidance, period-over-period comparisons, or other quantitative data were provided in the filing description. The sector was not specified.
03-02-2026
Maui Land & Pineapple Co Inc filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement. No details on the nature of the agreement, transaction value, financial impacts, or strategic implications are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or period-over-period comparisons are mentioned.
- Β·Filing Accession Number: 0001437749-26-002819
- Β·Filing Size: 158 KB
03-02-2026
Genworth Financial Inc filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-005054), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. No specific revenue, earnings, balance sheet details, guidance, or quantitative metrics are disclosed in the provided filing information. This is an informational earnings-related disclosure with no directional financial data available.
03-02-2026
Antero Midstream Corp filed an 8-K on February 3, 2026, disclosing under Item 2.01 the completion of an acquisition or disposition of assets. Item 8.01 covers other events, and Item 9.01 provides financial statements and exhibits. No specific transaction details, financial metrics, positive or negative changes, or quantitative data are disclosed.
03-02-2026
Prudential Financial Inc filed an 8-K on February 3, 2026, under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This multi-item filing discloses financial results but no specific quantitative metrics, period-over-period comparisons, or guidance details are provided in the filing summary. No positive, negative, or flat performance indicators are explicitly stated.
03-02-2026
AZZ INC filed an 8-K on 2026-02-03 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on affected positions, individuals, reasons for changes, quantitative data, or impacts are disclosed.
03-02-2026
Horace Mann Educators Corp /DE/ filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet effects, guidance changes, or period-over-period comparisons are explicitly disclosed in the provided filing information. This appears to be a standard voluntary earnings disclosure with attached exhibits containing detailed metrics.
03-02-2026
BOK Financial Corp filed an 8-K on February 3, 2026 (AccNo: 0000875357-26-000007, size: 137 KB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing involves voluntary disclosure of potentially material information to comply with Regulation FD, with exhibits likely attached such as press releases or presentations. No financial metrics, transactions, period-over-period comparisons, positive or negative changes, scheduled events, or other quantitative details are explicitly stated.
03-02-2026
Renasant Corp filed a Form 8-K on February 3, 2026, under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This multi-item filing provides voluntary disclosure of information with attached exhibits, but specific details of the disclosure, financial metrics, or transactions are NOT_DISCLOSED. No positive or negative metrics are mentioned.
03-02-2026
FIRST BUSINESS FINANCIAL SERVICES, INC. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035684, Size: 17 MB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing likely including voluntary disclosure of material information and attached exhibits such as a press release or presentation. No specific financial metrics, transactions, or events are detailed in the filing summary provided.
03-02-2026
Virtuix Holdings Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001213900-26-011493), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details regarding the other events, transaction values, financial metrics, or exhibits are disclosed in the provided filing information. This is a multi-item filing with limited visibility into materiality.
03-02-2026
Eva Live Inc filed an 8-K on February 03, 2026, reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the nature of the other events or the content of the financial statements and exhibits are disclosed. No quantitative metrics, transactions, or comparisons are mentioned.
03-02-2026
XMax Inc. filed a Form 8-K on February 3, 2026 (AccNo: 0001493152-26-004920, Size: 264 KB), reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No details on the agreement's terms, parties, value, financial impacts, or strategic context are provided.
- Β·AccNo: 0001493152-26-004920
- Β·File Size: 264 KB
- Β·Sector: NOT_DISCLOSED
03-02-2026
Dine Brands Global, Inc. filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, appointment or resignation status, reasons, or timing are disclosed. No quantitative metrics, financial data, or performance comparisons are mentioned.
03-02-2026
VPR Brands, LP filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01, with financial statements and exhibits attached under Item 9.01. No specific details regarding the agreement's terms, parties, value, or financial impacts are provided in the filing summary. This is an informational disclosure of a material event without quantified metrics.
03-02-2026
Comstock Inc. filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item voluntary filing to disclose potentially material non-public information and attach related exhibits. No specific details, financial metrics, transactions, or events are disclosed in the provided filing information.
03-02-2026
Viatris Inc filed an 8-K on February 3, 2026 (AccNo: 0001140361-26-003477), disclosing an officer change under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons for change, or any quantitative data such as compensation amounts are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
03-02-2026
SEMrush Holdings, Inc. filed an 8-K on February 3, 2026, disclosing under Item 5.07 the submission of matters to a vote of security holders, likely following a shareholder meeting, and under Item 9.01 financial statements and exhibits. No specific details on vote outcomes, proposals voted on, results, or contents of exhibits are provided. This appears to be a routine post-meeting informational filing with no quantified financial or operational impacts disclosed.
03-02-2026
GigCapital9 Corp. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035674, size: 304 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on the nature of the other events or the contents of the exhibits disclosed. No quantitative financial metrics, transactions, or directional impacts are provided.
03-02-2026
Veralto Corp filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing focused on financial results disclosure. No specific revenue, earnings, margins, guidance, period-over-period changes, or other quantitative metrics are disclosed in the provided filing information.
03-02-2026
Strive, Inc. filed a Form 8-K on 2026-02-03 reporting under Item 3.03 material modifications to the rights of security holders, under Item 5.03 amendments to articles of incorporation or bylaws or a change in fiscal year, and under Item 9.01 financial statements and exhibits. No specific details regarding the nature of the modifications, amendments, or any financial metrics are disclosed. No positive or negative impacts are quantified in the available information.
03-02-2026
Weatherford International plc filed an 8-K on 2026-02-03 under Item 2.02 announcing results of operations and financial condition, accompanied by Item 9.01 for financial statements and exhibits. No specific revenue, earnings, margins, or other quantitative financial metrics are disclosed in the provided filing information. This is a standard mandatory disclosure for financial results without detailed performance data available.
03-02-2026
03-02-2026
Radian Group Inc filed an 8-K on 2026-02-03 announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing also discloses Regulation FD information (Item 7.01), other events (Item 8.01), and includes financial statements and exhibits (Item 9.01). No specific transaction details, financial metrics, parties involved, or quantitative impacts are disclosed.
03-02-2026
Corteva, Inc. filed an 8-K on 2026-02-03 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific financial metrics, period-over-period comparisons, or quantitative data are explicitly stated in the provided filing information. This appears to be an informational earnings-related disclosure without detailed performance indicators.
03-02-2026
Atmos Energy Corp filed an 8-K on February 3, 2026, reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, margins, or period-over-period comparisons were disclosed in the filing metadata. This represents a standard voluntary disclosure of quarterly or periodic financial results.
03-02-2026
Dollar General Corp filed an 8-K on 2026-02-03 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details on the affected position, individual involved, appointment or resignation status, reasons, and any impacts are NOT_DISCLOSED.
03-02-2026
Star Equity Holdings, Inc. filed a Form 8-K on 2026-02-03 under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits), with Accession Number 0001210708-26-000013 and file size of 8 MB. No specific details regarding the Regulation FD disclosure content, financial statements, or exhibits are disclosed in the filing summary. This appears to be a voluntary disclosure of material information with attached exhibits.
03-02-2026
RenaissanceRe Holdings Ltd filed a Form 8-K on February 3, 2026 (AccNo: 0000913144-26-000003), reporting results of operations and financial condition under Item 2.02, with financial statements and exhibits attached under Item 9.01. This is a multi-item filing disclosing financial results, but no specific revenue, earnings, balance sheet details, period-over-period comparisons, or guidance are provided in the filing information. No positive or negative metrics are disclosed.
- Β·Filing size: 4 MB
- Β·Source: us_sec
- Β·Event Type: Financial Results
- Β·Sector: NOT_DISCLOSED
03-02-2026
Dominion Energy, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035749), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individual involved, reason for change, timing, or any quantitative impacts are disclosed. No positive or negative metrics, financial data, or governance implications are mentioned.
03-02-2026
Rent the Runway, Inc. filed an 8-K on 2026-02-03 disclosing entry into a Material Definitive Agreement under Item 1.01. Item 9.01 includes Financial Statements and Exhibits. No quantitative details, financial impacts, positive or negative metrics, or specific agreement terms are disclosed.
03-02-2026
Accel Entertainment, Inc. filed an 8-K on 2026-02-03 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative impacts are disclosed.
03-02-2026
OLB Group, Inc. filed a Form 8-K on 2026-02-03 under Item 3.01, disclosing a notice of delisting or failure to satisfy a continued listing rule or standard, or transfer of listing. This event signals potential removal from a U.S. exchange, negatively impacting liquidity and visibility. No financial metrics, transaction values, or other details such as reasons for delisting or future listing plans are disclosed.
03-02-2026
Tyler Technologies Inc filed an 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This is a multi-item filing with no specific details on the content of the disclosure or exhibits provided. No financial metrics, transactions, or operational data are disclosed.
03-02-2026
KKR Real Estate Finance Trust Inc. filed an 8-K on February 3, 2026 (AccNo: 0001628280-26-005088, Size: 6 MB), reporting results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific revenue, earnings, balance sheet changes, period-over-period comparisons, or other quantitative financial metrics were disclosed in the provided filing summary. No positive, negative, or flat performance indicators were detailed.
03-02-2026
Churchill Capital Corp X/Cayman filed a Form 8-K on 2026-02-03 under Accession Number 0001193125-26-035805, disclosing a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing per Item 3.01. The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No financial metrics, transaction values, dollar amounts, percentages, or additional details on the delisting reasons or impacts are disclosed.
03-02-2026
03-02-2026
Scilex Holding Co filed an 8-K on February 3, 2026, reporting under Item 3.03 material modifications to rights of security holders and under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year. Item 9.01 discloses financial statements and exhibits. No quantitative financial metrics, positive or negative changes, or specific details on the modifications or amendments are provided.
03-02-2026
Tavia Acquisition Corp. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or off-balance sheet arrangement under Item 2.03, with no specific positive or negative metrics provided. Financial statements and exhibits are included under Item 9.01. No deal structure details, valuations, or performance comparisons are disclosed.
- Β·Accession Number: 0001213900-26-011558
- Β·File Size: 273 KB
03-02-2026
Super Micro Computer, Inc. filed an 8-K on 2026-02-03 under Item 2.02 disclosing Results of Operations and Financial Condition, accompanied by Item 9.01 for Financial Statements and Exhibits. This is a standard earnings-related disclosure with no specific revenue, earnings, margins, or period-over-period metrics provided in the filing details. No positive or negative financial changes, guidance, or impacts were quantified.
03-02-2026
NOCERA, INC. filed a Form 8-K on 2026-02-03 disclosing under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard, along with transfer of listing implications. The multi-item filing also reports changes in certifying accountant (Item 4.01), departures or appointments of directors/officers including compensatory arrangements (Item 5.02), other events (Item 8.01), and financial statements/exhibits (Item 9.01). No quantitative financial metrics, transaction values, or period-over-period comparisons are disclosed.
03-02-2026
TrueBlue, Inc. filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01 and creation of a direct financial obligation or an obligation under an off-balance sheet arrangement under Item 2.03. Item 9.01 includes financial statements and exhibits. No specific transaction details, dollar values, financial impacts, or performance metrics are disclosed.
03-02-2026
03-02-2026
WYTEC INTERNATIONAL INC filed an 8-K on 2026-02-03 disclosing a material cybersecurity incident under Item 1.05. No financial impacts, remediation details, or quantitative effects were disclosed in the provided filing summary. This mandatory disclosure highlights operational risks inherent to cybersecurity events.
03-02-2026
PayPal Holdings, Inc. filed a Form 8-K on February 3, 2026, reporting under Item 5.02 on departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers, alongside Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item filing with no specific details on personnel changes, financial metrics, or quantitative impacts disclosed in the provided information. No positive or negative metrics are mentioned.
03-02-2026
03-02-2026
TREASURE GLOBAL INC filed an 8-K on 2026-02-03 disclosing entry into a material definitive agreement under Item 1.01. The filing also reports financial statements and exhibits under Item 9.01. No specific details, financial terms, metrics, or impacts are disclosed.
03-02-2026
WM Technology, Inc. filed a multi-item 8-K on February 3, 2026, reporting the termination of a material definitive agreement under Item 1.02 (potentially negative) and departure, election, or appointment of directors or certain officers along with compensatory arrangements under Item 5.02 (mixed implications depending on details). The filing also includes Regulation FD disclosure under Item 7.01, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No quantitative financial impacts, transaction values, or specific details on the events are disclosed.
03-02-2026
Reliance Global Group, Inc. filed a Form 8-K on February 3, 2026, disclosing entry into a material definitive agreement under Item 1.01, other events under Item 8.01, and financial statements and exhibits under Item 9.01. No specific details on the agreement, events, transaction values, financial impacts, or other metrics are disclosed in the provided filing summary. This is a multi-item filing with no quantitative data or period-over-period comparisons available.
03-02-2026
CERO Therapeutics Holdings, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001213900-26-011587), reporting under Item 3.01 a notice of delisting or failure to satisfy a continued listing rule or standard; transfer of listing. No financial metrics, transaction values, or other quantitative details were disclosed. Sector not specified.
03-02-2026
OLB Group, Inc. filed a Form 8-K on February 3, 2026, under Item 7.01 for Regulation FD Disclosure and Item 9.01 for Financial Statements and Exhibits. This multi-item filing includes voluntary disclosure likely accompanied by exhibits such as a press release. No quantitative financial metrics, transactions, period-over-period comparisons, or specific events are disclosed.
03-02-2026
HP Inc filed an 8-K on February 3, 2026, disclosing matters under Item 2.02 (Results of Operations and Financial Condition), Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers), Item 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). Specific details on leadership changes, financial metrics, governance amendments, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics are provided in the filing summary.
03-02-2026
ConnectM Technology Solutions, Inc. filed an 8-K on 2026-02-03 reporting Item 1.01 entry into a material definitive agreement, Item 2.03 creation of a direct financial obligation or off-balance sheet arrangement, and Item 3.02 unregistered sales of equity securities, with Item 9.01 providing financial statements and exhibits. No quantitative transaction details, dollar values, share counts, financial metrics, or performance comparisons are disclosed. The filing represents a multi-item disclosure of potentially strategic but dilutive events.
03-02-2026
Avidity Biosciences, Inc. filed an 8-K on February 3, 2026, reporting under Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on the core events, transactions, or financial metrics provided. No quantitative data, guidance, or scheduled events are disclosed.
03-02-2026
RING ENERGY, INC. filed an 8-K on 2026-02-03 disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), alongside Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected position, individual names, reasons for change, or any quantitative metrics are disclosed in the provided filing information. The event is categorized as an Officer Change with no further elaboration on positive or negative governance implications.
03-02-2026
Webster Financial Corp filed Form 8-K on February 3, 2026 (AccNo: 0001193125-26-035891), reporting under Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). Specific details of the other events and any attached financial statements or exhibits are NOT_DISCLOSED. No financial metrics, transactions, or impacts are mentioned in the filing summary.
03-02-2026
Odyssey Health, Inc. filed an 8-K on February 3, 2026, reporting under Item 1.01 entry into a material definitive agreement and under Item 2.03 the creation of a direct financial obligation or off-balance sheet arrangement. Item 9.01 discloses financial statements and exhibits. No quantitative details, transaction terms, dollar values, or financial impacts are provided.
03-02-2026
NUSATRIP Inc filed a Form 8-K on February 03, 2026, under Item 7.01 (Regulation FD Disclosure) and Item 8.01 (Other Events). No specific core events, financial metrics, transactions, or quantitative details are disclosed in the provided filing information. This appears to be a multi-item filing with no mentioned positive or negative performance metrics.
03-02-2026
AppTech Payments Corp. filed an 8-K on February 03, 2026, announcing the completion of an acquisition or disposition of assets under Item 2.01. The filing includes financial statements and exhibits under Item 9.01. No specific details on transaction parties, value, structure, or financial impacts are disclosed.
03-02-2026
Cannabist Co Holdings Inc. filed an 8-K on 2026-02-03 reporting under Item 1.01 entry into a Material Definitive Agreement. Item 9.01 discloses Financial Statements and Exhibits. No specific details, dollar values, financial impacts, or metrics were provided.
03-02-2026
K2 Capital Acquisition Corp filed an 8-K on 2026-02-03 (AccNo: 0001213900-26-011603) disclosing entry into a Material Definitive Agreement under Item 1.01, unregistered sales of equity securities under Item 3.02, amendments to articles of incorporation or bylaws or change in fiscal year under Item 5.03, and financial statements and exhibits under Item 9.01. No quantitative metrics, deal terms, parties beyond the filer, valuations, synergies, or performance comparisons are disclosed. Sector is not specified.
- Β·Sector not specified
- Β·File size: 1 MB
03-02-2026
AngioDynamics Inc filed an 8-K on 2026-02-03 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, names, reasons, or quantitative impacts were provided.
03-02-2026
Sight Sciences, Inc. filed an 8-K on February 3, 2026 (AccNo: 0001193125-26-035915), reporting under Item 1.01 entry into a material definitive agreement. No details on the agreement's nature, parties, financial terms, or impacts are disclosed in the provided filing summary. No quantitative metrics, positive or negative changes, or further context are mentioned.
03-02-2026
Nuveen Churchill Direct Lending Corp. filed an 8-K on 2026-02-03 disclosing Item 1.01 (Entry into a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement). This is a multi-item mandatory filing with no specific transaction details, dollar values, terms, or financial impacts provided. No quantitative metrics, positive or negative changes, or performance comparisons are disclosed.
Get daily alerts with 12 investment signals, 10 risk alerts, 10 opportunities and full AI analysis of all 291 filings
πΊπΈ More from United States
View all βMarch 25, 2026
US Pre-Market SEC Filings Roundup β March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings β March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings β March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC β March 24, 2026
US Executive Officer Management Changes SEC